Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.68
+0.21001.56%
Post-market: 13.680.00000.00%16:20 EDT
Volume:908.63K
Turnover:12.41M
Market Cap:2.22B
PE:620.74
High:13.82
Open:13.48
Low:13.45
Close:13.47
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.58
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.19
PE(LYR):308.14

Loading ...

Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold

TIPRANKS
·
Aug 04

Vertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth

TIPRANKS
·
Aug 04

Vertex: Buy Rating Reaffirmed Amid Near-Term Demand Headwinds and Strategic Transformation, Price Target Maintained at $20

TIPRANKS
·
Aug 04

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings
·
Aug 04

Vertex Names Chatelle Lynch Chief People Officer in Leadership Expansion

Reuters
·
Aug 04

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Dow Jones
·
Aug 04

Vertex is Maintained at Outperform by Baird

Dow Jones
·
Aug 04

Vertex Inc : Bmo Raises Target Price to $15 from $14

THOMSON REUTERS
·
Aug 04

Vertex price target lowered to $17 from $19 at Baird

TIPRANKS
·
Aug 04

Cantor Fitzgerald Adjusts PT on Vertex Pharmaceuticals to $595 From $590, Maintains Overweight Rating

MT Newswires Live
·
Aug 04

Analysts Offer Insights on Technology Companies: ON Semiconductor (ON), Palantir Technologies (PLTR) and Vertex (VERX)

TIPRANKS
·
Aug 04

Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)

TIPRANKS
·
Aug 04

Vertex Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 04

Vertex Q2 2026 earnings: Cloud growth lifts adjusted EBITDA margin to 25%

TradingKey
·
Aug 04

Vertex Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

MT Newswires Live
·
Aug 04

Vertex Q2 FY26 Net Income Swings to USD 9 Million; Revenue Rises 10.5% to USD 204 Million

Reuters
·
Aug 04

Vertex Q2 Adj. EPS $0.20 Beats $0.19 Estimate, Sales $203.970M Beat $202.296M Estimate

Benzinga Earnings
·
Aug 04